Related Experiment Video
Updated: Jun 24, 2026

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
The MATRIX study: evaluating the data in older adults.
1PENN Center for Continence and Pelvic Health, Division of Urology, University of Pennsylvania Medical Center, Philadelphia, USA.
The MATRIX study found oxybutynin transdermal system (OXY-TDS) effectively improved quality of life in older adults, including those 85 and older, with a low incidence of adverse events.
Area of Science:
- Gerontology
- Urology
- Pharmacology
Background:
- The MATRIX study evaluated the efficacy and safety of the oxybutynin transdermal system (OXY-TDS) in a large cohort of older adults.
- The study population included individuals over 65 years, with a specific focus on 131 participants aged 85 years and older.
- Many participants, despite being community-based, exhibited comorbidities and polypharmacy similar to those in long-term care.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
The Effect of Aging on Tissues

